Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,458,202 Peptidomimetic macrocycles with improved properties
The present invention provides biologically active peptidomimetic macrocycles with improved properties relative to their corresponding polypeptides. The...
US-9,458,201 Melanocortin receptor-specific heptapeptides
Melanocortin receptor-specific cyclic heptapeptides of the formula Z-Xaa.sup.1-Xaa.sup.2-Xaa.sup.3-Xaa.sup.4-Xaa.sup.5-Xaa.sup.6-Xaa.sup.7-Y (II) or a...
US-9,458,200 Method for producing intermediates for the production of novel macrocycles that are inhibitors of the...
The present invention relates to the use of particular macrocycles that are inhibitors of the proteasomic degradation of p27, in particular argyrin and...
US-9,458,199 Antigen surrogates in autoimmune disease
The present invention provides for the identification of an antigen surrogate to the native antigens for the autoimmune disease pemphigus vulgaris. Ligands are...
US-9,458,198 Cyclic peptide-based NPR-B agonists
Disclosed are cyclic, peptide-based novel compounds having NPR-B agonistic activity. Preferred compounds are cyclic peptides containing conventional or...
US-9,458,197 Elastin digest compositions and methods utilizing same
The present invention provides compositions for the therapeutic and/or cosmetic treatment of Elastin comprising tissues. Therapeutic and cosmetic compositions...
US-9,458,196 Synthetic peptides capable of binding to influenza hemagglutinin protein
The invention provides peptides capable of binding with influenza hemagglutinin (HA) protein blocking pH-induced shape change or aggregation of the influenza...
US-9,458,195 Melanocortin receptor ligands
The present invention is directed to compounds according to formula, (R.sup.2R.sup.3)-A.sup.1-c(A.sup.2-A.sup.3-A.sup.4-A.sup.5-A.sup.6-A.sup.- ...
US-9,458,194 Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions
Compounds of general formula (I): their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, cosmetic and/or...
US-9,458,193 Proline compounds as Granzyme B inhibitors
Proline compounds as Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. Methods for treating cutaneous...
US-9,458,192 Covalent granzyme B inhibitors
Covalent Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. A method for treating cutaneous scleroderma,...
US-9,458,191 Nanolipoprotein particles and related methods and systems for protein capture, solubilization, and/or purification
Provided herein are methods and systems for assembling, solubilizing and/or purifying a membrane associated protein in a nanolipoprotein particle, which...
US-9,458,190 Extraction and partitioning of molecules
Methods of extracting a component of interest from a plurality of components are described.
US-9,458,189 Ligation of stapled polypeptides
The present invention provides technology for making large (e.g., greater than 50 amino acids), semi-synthetic, stapled or stitched proteins. The method...
US-9,458,188 Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (G) quinazoline...
A new method for the synthesis of L-Glutamyl-.gamma.-D-Glutamic acid and its use in the synthesis of ...
US-9,458,187 Methods for treatment of inflammatory conditions using S-[4-(3-fleuro-3-methylbutyryloxy)but-2-ynyl]6.alpha., ...
The present invention relates to methods of treatment of inflammatory conditions using ...
US-9,458,186 Polysaccharide derivative, method for producing the same, and separating agent
An object of the present invention is to provide a novel polysaccharide derivative used for a separating agent for optical isomers. The novel polysaccharide...
US-9,458,185 First row metal-based catalysts for hydosilylation
In various embodiments, the invention provides phosphine ligand supported first row metal catalysts with surprising and efficacious catalytic activity for...
US-9,458,184 Compositions of TLR7 and/or TLR8 agonists conjugated to lipids
A conjugated compound of formula Q-Z--R.sup.4 wherein Q is a TLR7 and/or TLR8 agonist and Z--R.sup.4 is a lipid covalently linked to an amino acid or peptide...
US-9,458,183 Method of synthesizing siloxane monomers and use thereof
A method for preparation and polymerization of siloxane monomers of Formula I is presented. The synthesis includes the selective reaction between silanol...
US-9,458,182 Silyl- and heteroatom-substituted compounds selected from carbazoles, dibenzofurans, dibenzothiophenes and...
The present invention relates to silyl- and heteroatom-substituted compounds selected from carbazoles, dibenzofurans, dibenzothiophenes and ...
US-9,458,181 Cathepsin cysteine protease inhibitors
This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and...
US-9,458,180 Method for preparation of cyano compounds of the 13th group with a lewis acid
The invention discloses a method for preparation of cyano compounds of the 13th group of the periodic table with 1, 2, 3 or 4 cyano residues, represented by...
US-9,458,179 Quinuclidine, 1-azabicyclo[2.2.1]heptane, 1-azabicyclo [3.2.1]octane, and 1-azabicyclo[3.2.2]nonane compounds...
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands for...
US-9,458,178 Spiro-oxindole compounds and their use as therapeutic agents
This invention is directed to spiro-oxindole compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable...
US-9,458,177 Oxazolidin-2-one compounds and uses thereof
The present invention relates to oxazolidin-2-one substituted pyrimidine compounds that act as PI3K (phosphatidylinositol-3-kinase) inhibitors, as well as...
US-9,458,176 Tetrahydroimidazo(1,5-D)[1,4]oxazepine derivative
A compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof works as an mGluR2 antagonist, and is applicable as a...
US-9,458,175 MK2 inhibitors and uses thereof
The present invention provides compounds, compositions thereof, and methods of using the same.
US-9,458,174 Inhibitors of the activity of complex (III) of the mitochondrial electron transport chain and use thereof
The present invention relates to inhibitors of the activity of Complex (III) of the mitochondrial electron transport chain and use thereof in treatment and/or...
US-9,458,173 Amides of 2-amino-4-arylthiazole compounds and their salts
The present disclosure is directed to salts of N-{4-[2,4-difluoro-3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl}dimethyl-2- ...
US-9,458,172 Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives
Disclosed are certain pyridinyl and pyrimidinyl sulfoxide and sulfone compounds, pharmaceutical compositions comprising such compounds and methods of treatment...
US-9,458,171 Pyrrolidinyl sulfone ROR.gamma. modulators
Described are ROR.gamma. modulators of the formula (I), ##STR00001## or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs...
US-9,458,170 Compound of camptothecin and preparation and use thereof
The present disclosure relates to a compound of formula I, a pharmaceutical composition thereof and the use thereof as an anti-tumor drug. ##STR00001##
US-9,458,169 Crystalline forms of therapeutic compounds and uses thereof
Described herein is certain crystalline forms of Compound 3, as well as pharmaceutical compositions employing the crystalline forms. Also provided are particles...
US-9,458,168 Bicyclic-fused heteroaryl or aryl compounds
Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia, ##STR00001##...
US-9,458,167 Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
The present invention provides tricyclic compounds, pharmaceutically acceptable salts, prodrugs, solvates, or hydrates thereof, having antimitotic activity,...
US-9,458,166 Oligomer-opioid agonist conjugates
The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered...
US-9,458,165 DOT1L inhibitors
Provided herein are inhibitors of DOT1L of formula (I) useful for treating diseases or disorders associated with DOT1L: ##STR00001## in which R.sup.1 is...
US-9,458,164 Pyrrolopyridazines as potassium ion channel inhibitors
A compound of formula (I) wherein A, R.sup.1, R.sup.3, and R.sup.24 are described herein. The compounds are useful as inhibitors of potassium channel function...
US-9,458,163 Heterocyclic derivatives
The invention relates to novel heterocyclic compounds of the formula ##STR00001## in which all of the variables are as defined in the specification, to their...
US-9,458,162 Cyclic molecules as bruton's tyrosine kinase inhibitors
The present document describes novel molecules having protein tyrosine kinase inhibitory activity, and methods of synthesizing and using such compounds. More...
US-9,458,161 TSPO ligands for cancer imaging and treatment
Embodiments of the present invention relates to compounds of the following formula: ##STR00001## as well as compositions, methods of imaging and methods of...
US-9,458,160 Peripherally restricted diphenyl purine derivatives
The invention provides compounds capable of acting as antagonists at cannabanoid receptors according to the following formula: ##STR00001## Such compounds may...
US-9,458,159 Substituted pyrido[1',2':4,5]pyrazino[1,2-a]azepines for treating viral infections
Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I): ##STR00001## ...
US-9,458,158 Bicyclic heterocycle compounds and their uses in therapy
The invention relates to bicyclic heterocycle compounds of formula (I): or tautomeric or stereochemically isomeric forms, N-oxides, pharmaceutically acceptable...
US-9,458,157 Pyrazole derivative
It has been desired to develop a pharmaceutical composition, which is used in agents for preventing and/or treating various diseases related to PDE10 (e.g....
US-9,458,156 Tricyclic compounds as anticancer agents
The present invention is directed to tricyclic compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using...
US-9,458,155 Pyrido[4,3-b]indoles containing rigid moieties
This disclosure is directed to pyrido[4,3-b]indoles having rigid moieties. The compounds in one embodiment are pyrido[4,3-b]indoles having an unsaturated...
US-9,458,154 Kinase inhibitors
Disclosed are compounds having [1,2,4]triazolo[4,3-a]pyridine groups and pharmaceutically acceptable salts thereof. The compounds are p38 MAPK inhibitors,...
US-9,458,153 Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection
The invention provides novel compounds having the general formula: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are as...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.